{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:30:42Z","timestamp":1759815042182},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lab Med"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1093\/labmed\/lmw037","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T01:10:21Z","timestamp":1467681021000},"page":"e35-e37","source":"Crossref","is-referenced-by-count":6,"title":["Successful Use of Four Factor-Prothrombin Complex Concentrate for Congenital Factor X Deficiency in the Setting of Neurosurgery"],"prefix":"10.1093","volume":"47","author":[{"given":"Alexa J.","family":"Siddon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Tormey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,7,4]]},"reference":[{"key":"2016071209022019000_47.3.e35.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01856.x"},{"key":"2016071209022019000_47.3.e35.2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2014-0366-RS"},{"key":"2016071209022019000_47.3.e35.3","unstructured":"News release. Washington, DC: Food and Drug Administration. FDA approves first factor X concentrate to treat patients with rare hereditary bleeding disorder. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm468038.htm. Accessed June 6, 2016."},{"key":"2016071209022019000_47.3.e35.4","first-page":"203","article-title":"Blood product support for delivery in severe factor X deficiency: the use of thrombin generation to guide therapy","volume":"5","author":"van Veen","year":"2007","journal-title":"Blood Transfus"},{"key":"2016071209022019000_47.3.e35.5","first-page":"13403","article-title":"Surgical treatment for a paraplegic patient induced by congenital factor X deficiency","volume":"8","author":"Lin","year":"2015","journal-title":"Int J Clin Exp Med."},{"key":"2016071209022019000_47.3.e35.6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/trf.13464","article-title":"Four-factor prothrombin complex concentrates for warfarin reversal: do real-world outcomes differ from controlled clinical trials?","volume":"56","author":"Pruthi","year":"2016","journal-title":"Transfusion."},{"key":"2016071209022019000_47.3.e35.7","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-01-0052"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/47\/3\/e35\/14141815\/lmw037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T11:33:09Z","timestamp":1503574389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article-lookup\/doi\/10.1093\/labmed\/lmw037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,4]]},"references-count":7,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,7,12]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.1093\/labmed\/lmw037"],"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmw037","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,4]]}}}